Tamoxifen metabolism predicts drug concentrations and outcome in premenopausal patients with early breast cancer
2014 · The Pharmacogenomics Journal · 197 citations
https://doi.org/10.1038/tpj.2014.34
W
Werner Schroth
Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology(DE)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
434
Papers
6.6K
Citations
33
h-index
132
i10-index
Werner Schroth is an academic researcher from Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology. The author has contributed to research in topics: Estrogen and related hormone effects & Pharmacogenetics and Drug Metabolism & Organic Chemistry Cycloaddition Reactions. The author has an h-index of 33, co-authored 369 publications.
ORCID: 0000-0003-1412-4592Papers by this author
worksGene Expression Signatures of BRCAness and Tumor Inflammation Define Subgroups of Early-Stage Hormone Receptor–Positive Breast Cancer Patients
2020 · Clinical Cancer Research · 43 citations
https://doi.org/10.1158/1078-0432.ccr-20-1923
The Influences of Adherence to Tamoxifen and <i>CYP2D6</i> Pharmacogenetics on Plasma Concentrations of the Active Metabolite (Z)‐Endoxifen in Breast Cancer
2019 · Clinical and Translational Science · 18 citations
https://doi.org/10.1111/cts.12707
Transcription factors of the Nuclear Factor I (NFI) family control hepatocyte differentiation and cytochrome P450 activity in human liver
2025 · Pharmacological Research · 3 citations
https://doi.org/10.1016/j.phrs.2025.107998
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat